GSTP1 and neoplasm: In some cases, promoter hypermethylation has been correlated with specific tumor characteristics, such as GSTP1 methylation with increased tumor size, the occurrence of CDH1 methylation in estrogen receptor (ESR1)-negative tumors and the frequent appearance of RAR-β 2 hypermethylation in HER2-positive tumors [23].